For many patients, hyperpigmentation isn’t just a “dark spot issue”—it’s a confidence issue. For the clinicians treating it, melasma and post-inflammatory hyperpigmentation (PIH) can be some of the most nuanced concerns in aesthetic dermatology, particularly when devices and procedures enter the plan.

This is exactly why our upcoming webinar on Corrective Microneedling™ in the Treatment of Hyperpigmentation with Beverly Hills dermatologist Dr. Haleh Bakshandeh is focused on clinical nuance, not one-size-fits-all fixes.

You can also explore our main deep dive on this topic in the earlier article, The Science Behind Corrective Microneedling™ for Hyperpigmentation.

Melasma vs. PIH: Same Canvas, Different Stories

Clinically, melasma appears as symmetric patches of brown or gray-brown discoloration, often on the cheeks, forehead, upper lip or jawline. It’s closely tied to hormones, UV exposure and heat, making it a chronic, relapsing condition rather than a one-time event.

PIH, on the other hand, is hyperpigmentation that follows an “insult” to the skin—acne, eczema, burns, aesthetic procedures or even overly aggressive at-home care. Once the inflammation resolves, pigment can linger as macules or patches for weeks to months, and in some cases, longer.

Why They Respond Differently to Treatment

Melasma behaves more like a systemic, trigger-sensitive disorder. Even when you achieve visible clearance, a vacation without SPF or a hormonal shift can bring it back. Management is often long-term and maintenance-based rather than “curative,” which is crucial to communicate to patients upfront.

PIH is more directly linked to the intensity and duration of inflammation. Control the trigger, protect the barrier and reduce ongoing irritation, and PIH is often more responsive and predictable—though not always fast.

The Role of Inflammation in Pigment Pathways

Both melasma and PIH share one key theme: inflammation as a driver of melanocyte activity. Inflammation activates a cascade of signaling molecules that can upregulate melanin production and alter how pigment is distributed in the epidermis and dermis.

For clinicians, this means any procedure, product or technique that amplifies inflammation without strategy can worsen the very pigmentation you’re trying to treat—especially in melanin-rich skin. This is where a more controlled microneedling philosophy becomes essential.

Where Corrective Microneedling™ Fits In

Microneedling has earned its place in the treatment room for texture, scarring and overall skin quality. But when hyperpigmentation is on the table, it isn’t just about “stimulation”—it’s about controlled stimulation.

Corrective Microneedling™ emphasizes:

• Intentional microchannel density (how many channels, how closely spaced)
• Precise depth selection based on indication, anatomical zone and skin type
• Technique that respects pigment-prone and previously inflamed skin

This more measured approach can support epidermal renewal and dermal remodelingin a way that encourages more even tone—without tipping the skin into a high-risk inflammatory state.

Treating Melasma with Corrective Microneedling™

In melasma, the goal is to quiet pigment pathways while improving skin quality and barrier resilience. Corrective Microneedling™ may be used as part of a broader protocol that includes pigment-regulating topicals, antioxidant support and rigorous photoprotection.

Rather than relying on aggressive passes or excessive depth, the emphasis is on subtle, repeated signaling to the skin: prompting renewal, supporting collagen and improving product penetration—without overheating or over-inflaming the tissue.

Addressing PIH: Precision Around Previous Injury

With PIH, Corrective Microneedling™ can be particularly valuable around areas of prior injury or inflammation, such as acne scars. The focus is on:

• Improving texture and atrophic scarring
• Supporting even melanin distribution as the epidermis renews
• Avoiding additional trauma that could prolong or worsen pigment

Here, patient selection, timing after the initial injury and meticulous post-care become critical to success.

Clinical Considerations You Can’t Skip

When building treatment plans for melasma and PIH, a few non-negotiables emerge:

• Detailed history: Hormonal factors, medication use, heat and sun exposure patterns, and exfoliant/retinoid use.
• Fitzpatrick type: Especially important when you’re considering microneedling in types IV–VI.
• Barrier status: Compromised skin is far more likely to react poorly and pigment unevenly.
• Expectations: Patients with melasma need to understand the concept of management and maintenance, not just “removal.”

Corrective Microneedling™ works best when it’s layered onto a thoughtful plan that includes high quality skincare—not used in isolation.

Talking to Patients About Realistic Outcomes

Patients often arrive wanting “complete clearance.” Setting realistic expectations is as important as your device settings:

• Melasma: Emphasize gradual improvement, maintenance treatments and lifestyle support.
• PIH: Highlight that color can fade significantly but may take multiple sessions and strict adherence to aftercare.

Positioning Corrective Microneedling™ as part of a comprehensive protocol—rather than a miracle fix—helps align outcomes with reality and improves long-term satisfaction.

Join the Deeper Dive with Dr. Bakshandeh

If you’re ready to refine your approach to melasma and PIH, our upcoming webinar is designed to translate science into practice.

Corrective Microneedling™ in the Treatment of Hyperpigmentation

• When: March 25
• Featuring: Dr. Haleh Bakshandeh, Board-Certified Dermatologist, Beverly Hills, CA
• Where: Hosted by MDPen
• Who it’s for: licensed Medical aesthetic practitioners and  professionals 

In this session, Dr. Bakshandeh will share how she approaches melasma and PIH in her own practice—what she does, what she avoids and how to use Corrective Microneedling™ to support clearer, more even-toned skin safely.